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Abstract
Herpes simplex virus type 1 (HSV-1) glycoproteins H and L (gH and gL) are required for virus-induced membrane fusion. Expression of gH at
the virion or infected cell surface is mediated by the chaperone-like activity of gL. We have previously shown that a region between amino acids
155 and 161 is critical for gL chaperone-like activity. Here, we conducted Ala substitution mutagenesis of residues in this region and found that
substitution of Cys160, Arg156, Arg158, or Arg156/158/159 with Ala resulted in a gL mutant that bound gH but displayed a reduced ability in gH
trafficking and membrane fusion. Substitution of Arg156 with another positively charged amino acid, Lys, restored function. Substitution of
Arg158 with Lys restored function in gH trafficking and cell fusion but not virus entry. These results indicate that an arginine-rich region of gL is
critical for function.
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Herpes simplex virus (HSV) is enveloped by a lipid bilayer
and at least a dozen glycoproteins. The virion surface
glycoproteins mediate recognition of susceptible cells and
promote fusion of the viral envelope with the cell membrane,
leading to virus entry. Membrane fusion mediated by viral
glycoproteins can also be observed in cell culture by mixing a
population of cells expressing only a subset of the envelope
glycoproteins, specifically glycoproteins B (gB), gD, gH and
gL, with cells expressing a gD receptor (Pertel et al., 2001;
Turner et al., 1998). No single protein has been identified as the
HSV fusogen. Expression of gD and gH–gL mediates
hemifusion but not full fusion (Subramanian and Geraghty,
2007) indicating that the fusion process may occur by the
sequential activities of gD, gH–gL, and gB.
HSV-1 gH contains 838 amino acids (Gompels and Minson,
1986) and displays characteristics of both class I and class II
fusion proteins. Similarly to class I fusion proteins, gH may
contain heptad repeats and a fusion peptide (Gianni et al., 2005).⁎ Corresponding author. Fax: +1 859 257 8994.
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doi:10.1016/j.virol.2007.11.014Peptides derived from the heptad-repeat region inhibit virus
entry (Galdiero et al., 2005; Gianni et al., 2005). Similarly to
class II fusion proteins (Jardetzky and Lamb, 2004; Lorenz et
al., 2002; Op De Beeck et al., 2000), gH forms a non-covalent
complex with a viral chaperone protein (gL) that is required for
proper cell-surface expression (Dubin and Jiang, 1995).
HSV-1 gL is a 224-amino-acid glycoprotein that forms a
non-covalently linked heterodimer with gH (Hutchinson et al.,
1992; Peng et al., 1998; Roop et al., 1993). This heterodimer is
essential for virus–cell and cell–cell fusion since the association
of gH and gL is necessary for the localization of HSV-1 gH to
the virion or cell surface (Hutchinson et al., 1992; Peng et al.,
1998). Upon co-expression with gL, gH anchors the hetero-
dimer to the plasma membrane through its transmembrane
domain (Dubin and Jiang, 1995). HSV-1 gL lacks a transmem-
brane domain and is secreted from cells when expressed in the
absence of gH (Dubin and Jiang, 1995). Heterodimer formation
may be important for proper folding of gH because the anti-gH
conformation-dependent monoclonal antibodies (mAbs) 53S
and LP11 bind gH only when gL is present (Gompels and
Minson, 1986, 1989).
A goal of our studies is to understand the function of gL in
membrane fusion. A well-documented role for gL in fusion is
Fig. 1. Diagram of gL substitution and deletion mutants. The region of gL that is
critical for function is indicated (155–161). Wild-type gL contains 224 amino
acids. Amino acid numbers, starting with the initiator Met, were based on
GenBank accession no. AAM78607. ‘C’ indicates cysteine. Wild-type gL and
all gL mutants have an HA-epitope tag (black box) fused to their carboxy
terminus. Drawing is not to scale.
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virion or the cell. However, N-terminal mutants of HSV-2 gH
that are trafficked to cell surface in the absence of gL still
require gL for fusion suggesting a role for gL other than gH
trafficking (Cairns et al., 2007). Furthermore, mAbs to HSV-1
gL can block cell fusion (Novotny et al., 1996) again
suggesting that HSV-1 gL may have another role in membrane
fusion.
The association of gL with gH is necessary but not sufficient
to mediate appropriate gH localization and function in fusion
(Klyachkin et al., 2006). However, further details regarding the
mechanism of gL function are lacking. Previous deletion
analysis revealed a critical region of gL between amino acids
155 and 161, such that a mutant containing the amino terminal
161 amino acids (gL161), but not a mutant containing the amino
terminal 155 amino acids (gL155), retained function in gH
transport and cell–cell fusion (Klyachkin et al., 2006; Peng et
al., 1998). A Cys residue at position 160 is critical for gH
transport (Cairns et al., 2005). Cys residues are clearly
important because mutation of any gL Cys (positions 44, 76,
149, or 160) renders a protein unable to traffic gH and
contributes to cell fusion (Cairns et al., 2005).
To gain a better understanding of gL function, we used
substitution mutagenesis to identify critical amino acids in the
155–161 region. Our systematic analysis of the region provided
the following findings: (i) the addition of a Cys residue to
gL155 was not sufficient to complement its defect, indicating
that amino acids between 155 and 161, other than Cys 160, were
important for gH transport, (ii) Ala substitution analysis of
amino acids in positions 156–160 indicated that Arg156,
Arg158, and Cys 160 were important for gH transport, (iii) Lys
substitution for Arg at position 156 enhanced gH transport and
cell–cell fusion compared to wild-type gL, while Lys substitu-
tion for Arg at position 158 restored gH trafficking and cell
fusion but not virus entry. Taken together, these results indicate
that in addition to containing an essential Cys residue, the 155–
161 region is important for gL function possibly by containing
positively charged amino acids.
Results
Expression of gL Cys mutants and ability to bind gH
Because Cys residues are often critical for disulfide bonds
and protein structure, we wanted to determine if Cys160 was the
only amino acid between 155 and 161 that was important for
function. We examined the importance of the Cys residue at
position 160 by substituting an Ala in full-length gL, C160A,
and creating two deletion mutants, gL 155-Cys and gL 155-4A-
Cys (Fig. 1). The rationale for generating the latter two mutants
was to determine if a Cys residue could complement the
nonfunctional gL155 (mutant contains only three of the four
required Cys residues). Complementation would indicate that
the Cys residue was the only important residue in the 155–161
region. By adding back the Cys at either position 156 or 160, we
can address the importance of the location of the fourth Cys in
gL function.Previously described gL deletion mutants were expressed at
1–8% of wild-type gL (Klyachkin et al., 2006). To determine
the level of gL Cys mutant expression compared to wild-type
gL, CHO cells were transfected with plasmids expressing gL or
gL Cys mutants and the resulting cell lysates were subjected to
SDS-PAGE and Western blotting. Since all forms of gL have an
HA-epitope tag fused to the C-terminus (Fig. 1), mutant
expression was detected using an anti-HA MAb. The Cys
substitution mutant C160Awas expressed at about 90% of wild-
type gL (Fig. 2A, lane 7), indicating that the mutation had little
or no effect on overall protein expression. In contrast, the
deletion mutants gL 155-Cys and gL 155-4A-Cys were
expressed at approximately 20% and 7% of wild-type gL,
respectively (Fig. 2A), consistent with our previous study of
similar deletion mutants (Klyachkin et al., 2006). The gL 155-
Cys and gL 155-4A-Cys mutants were expressed at levels
higher than the previously described functional gL 161 deletion
mutant (Fig. 2B) (Klyachkin et al., 2006), indicating that the
reduced steady-state levels of gL 155-Cys and gL 155-4A-Cys
should not preclude analysis of their function. The reduced
intracellular level of the deletion mutants could be a result of an
abnormally high rate of secretion or perhaps due to an increased
instability of the mutants. We currently favor the latter because
the levels of gL deletion mutants in the culture supernatant of
cells mirror their intracellular expression levels, both vastly
reduced compared to wild-type gL (Klyachkin et al., 2006). We
detect two bands for gL and mutants with an intact C-terminus
Fig. 3. Co-immunoprecipitation of gL deletion mutants from cells co-expressing
gH. CHO-K1 cells were transfected with a plasmid expressing gH and a plasmid
expressing wild-type gL or mutant, a plasmid expressing gL and pcDNA3 (gL
alone), or mock-transfected (Mock). Cells were immunoprecipitated with anti-
gH mAb 52S. Immunoprecipitates were subjected to SDS-PAGE and transferred
to nitrocellulose. Western blotting was performed by using an anti-HA mAb to
detect gL and visualized via enhanced chemiluminescence.
Fig. 2. Total cellular expression of gL mutants. (A) CHO-K1 cells transfected
with plasmids expressing wild-type gL, a gL mutant, or control plasmid were
processed for SDS-PAGE and Western blotting. Proteins were detected using rat
anti-HA and anti-rat IgG conjugated to Alexa Fluor 680 dye. Quantitation was
performed via LI-COR® Odyssey Infrared Imaging System. (B) Comparison of
steady-state expression levels of gL155-Cys and gL155-4A-Cys to the
functional gL deletion mutant gL161.
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prominent band is likely a mature form of gL while the lower
less prominent band is likely an immature form, although that
has yet to be demonstrated. A previous study using a polyclonal
antibody detected only the immature form of wild-type gL when
it was expressed in 293 cells without gH (Cairns et al., 2005). It
is unclear why the majority of gL we detect appears to be a
mature form but our use of CHO cells and an antibody to the
HA tag at the C-terminus of gL and mutants are obvious
differences that may contribute.
When gH and gL are co-expressed, gH binds gL in the
endoplasmic reticulum and is trafficked to the surface of the cell
(Dubin and Jiang, 1995). To determine whether gL Cys mutants
formed a complex with gH, we performed co-immunoprecipita-
tion and Western blot analysis. Cells co-expressing gH and gL
Cys mutants or gH and wild-type gL were lysed and
immunoprecipitated with anti-gH mAb 52S (Showalter et al.,
1981). The 52S mAb is a conformation-dependent Ab that binds
gH independently of gL (Gompels and Minson, 1986, 1989).
The immunoprecipitated proteins were subjected to Western
blot analysis using an anti-HA mAb. All gL Cys mutants co-
immunoprecipitated with the anti-gH antibody, indicating that
all mutants interacted with gH (Fig. 3; lanes 7, 10–11).
Surprisingly, the level of gL truncation mutants associated with
gH was equal or greater than wild-type gL, despite the total
cellular levels of the deletion mutants being much lower whenexpressed in the absence of gH (Fig. 2A). Although we have not
taken steps to ensure the co-immunoprecipitation experiment is
quantitative, the deletion mutants may be unstable and perhaps
degraded when expressed in the absence of gH but upon
binding gH, they may be stabilized. Overall, our immunopre-
cipitation results are consistent with our previous study where
deletion mutants consisting of 155, 150, and 147 amino-
terminal amino acids of gL bound gH (Klyachkin et al., 2006).
gL Cys mutants do not mediate gH surface expression and
therefore do not mediate membrane fusion
Previous analysis identified gL mutants that bind gH but are
unable to transport gH to the cell surface, and subsequently do
not promote membrane fusion, indicating that gL binding was
necessary but not sufficient for gH function (Klyachkin et al.,
2006). To determine the ability of gL Cys mutants to mediate
cell–cell fusion we employed a cell-mixing fusion assay. CHO-
K1 cells were split into two populations, effector cells and
target cells. Effector cells were transfected with the plasmids
expressing the HSV-1 fusion glycoproteins gB, gD, gH, gL or
one of the gL Cys mutants and T7 RNA polymerase. Target
CHO-K1 cells were transfected with a plasmid expressing the
gD receptor nectin-1 and a plasmid with the Escherichia coli
lacZ gene under control of the T7 promoter. CHO-K1 cells are
normally resistant to HSV-1-induced fusion and must express a
gD receptor to fuse with HSV-1 envelope glycoprotein-
expressing cells (Jones and Geraghty, 2004; Pertel et al.,
2001). To determine the ability of the gL Cys mutants to
contribute to envelope glycoprotein-induced fusion, we mixed
the effector cells and target cells at a 1:1 ratio. Fusion of the two
cell populations will result in content mixing and induction of
β-galactosidase (β-gal) expression. β-Gal activity was mea-
sured as an indication of the extent of fusion. Cell-surface
expression of gH was measured in parallel by CELISA. C160A
did not promote fusion, not surprising due to an inability to
traffic gH to the cell surface (Fig. 4A). This result is in
agreement with previously published data (Cairns et al., 2005).
Fig. 4. Ability of gL mutants to mediate fusion and gH trafficking. Fusion and CELISA assays. Fusion assay (left graph). Cells expressing envelope glycoproteins:
gL=cells transfected with gB, gD, gH, gL and plasmid expressing T7 pol; gL−=cells transfected with gB, gD, gH, T7 pol and control plasmid pCAGGS. gL mutants
were individually substituted for wild-type gL. Cells expressing receptor: nectin-1=cells transfected with plasmid expressing gD receptor nectin-1 and inducible β-Gal
plasmid under the control of T7 promoter (pG1NT7β-gal); CD4=cells transfected with plasmid expressing HIV receptor CD4 and pG1NT7β-gal. Within each
experiment, values were expressed as a percentage of that obtained for the positive control, gL/nectin-1. Mean relative values and standard deviations (SD) from at
least three independent experiments are shown. CELISA assay (right graph). Envelope glycoprotein-expressing cells used in the fusion assay were analyzed for their
cell-surface expression of gH via anti-gH mAb 52S. Within each experiment, values were expressed as a percentage of the positive-control transfection, gL. Mean
relative values and SD from at least three independent experiments are shown. (A) gL Cys mutants; (B) gL point mutants.
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surface expression (Fig. 4A), indicating that the addition of a
Cys at position 156 or 160 was not sufficient to complement the
defect in gL 155. It should be noted we have not demonstrated
that the deletion mutants form disulfide bonds similarly to wild-
type gL. These results indicate that other amino acids in gL
region 155–161 must be important for transport of gH,
although we have not ruled out defective disulfide bond
formation as an alternative explanation for the deficiencies of
155-Cys and 155-4A-Cys.
Amino acid substitutions in gL region 155–161
To investigate the importance of amino acids in the region
between residues 155 and 161, we created a panel of point
mutants in full-length gL (Fig. 1). The Arg residues were
substituted with Ala either individually (R156A, R158A, or
R159A) or together (R156,158,159A). We also substituted Arg
with Lys for any nonfunctional Arg to Ala substitutions
(R156K, R158K) to assess the importance of the residue charge
in the region. The Thr was substituted with an Ala (T157A). The
amino acid substitutions had no effect on protein expression
since the steady-state levels of all point mutants were at or nearthe levels of wild-type gL as measured by Western blot analysis
and quantitation (Fig. 2A, lanes 2–6, 8–9). The ability of gL
substitution mutants to bind gH was assessed by co-immuno-
precipitation andWestern blot. All gL substitution mutants were
immunoprecipitated by anti-gH mAb indicating gH binding
(Fig. 3, lanes 2–6, 8–9). Certain gL mutants had two forms
associated with gH, especially R158A; R156,158,159A; and
C160A. The lower form is likely an immature gL that has not
trafficked through the Golgi suggests that a percentage of those
gH–gL mutant heterodimers are retained in the endoplasmic
reticulum.
gL substitution mutants have differential effects on gH surface
expression and fusion
The ability of gL substitution mutants to mediate gH cell-
surface expression and cell–cell fusion was assessed by
CELISA and cell-mixing fusion assay. Substitution of Arg156
with an Ala (R156A) resulted in a modest ≈30% reduction of
cell–cell fusion but had no effect on gH cell-surface expression
(Fig. 4B). Interestingly, substitution of Arg156 with a Lys
(R156K) resulted in slightly increased level of cell–cell fusion
and gH trafficking compared to wild-type gL (Fig. 4B). These
Fig. 5. Ability of gL mutants to complement a gL− virus. Vero cells were
transfected with plasmids expressing gL mutants and inoculated with HSV-1
(KOS)gL86 grown on gL complementing cells. Forty-eight hours later culture
supernatants containing complemented virions were harvested and diluted 2-
fold, 4-fold, and 8-fold; “No virus” indicates culture supernatant without virus.
The virus dilutions were overlaid onto nectin-1-expressing CHO (HveC-1) cells.
β-Gal activity was measured by addition of substrate, ONPG, and spectrometry
as an indication of virus entry. (A) gL Cys mutants; (B) Arg to Ala substitution
mutants; (C) Arg to Lys substitution mutants.
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important at residue 156, although more extensive mutagenesis
is required to establish this with certainty. Substitution of
Arg158 with Ala (R158A) resulted in ≈60% reduction in gH
cell-surface expression and a corresponding reduction in cell–
cell fusion (Fig. 4B). Substitution of Arg158 with Lys (R158K)
restored function to wild-type gL level, again suggesting that a
residue with a positively charged side chain is important at
position 158 (Fig. 4B). Substitution of Arg159 with an Ala
(R159A) had no effect on cell–cell fusion but was ≈20% less
effective in gH cell-surface expression (Fig. 4B). Substitution of
all three Arg in gL region 155–161 (R156,158,159A) resulted
in ≈80% reduction in gH cell-surface expression and cell–cell
fusion indicating an additive effect when all three Arg are
replaced (Fig. 4B). Substitution of Thr 157 had no effect on gL
function (Fig. 4B). Together these results suggest that the Arg
residues in gL region 155–161, Arg158 in particular, are
important for trafficking of gH. Because Lys substitution
restored function, a positively charged side chain for residues in
that region may be important. Lastly, gL mutants with the
largest proportion of immature gL associated with gH, R158A;
R156,158,159A; and C160A (Fig. 3), were also the most
restricted for gH transport to the cell surface (Fig 4B). This is
consistent with the idea that a relatively large percentage of
those gH–gL mutant heterodimers have not been transported to
the Golgi apparatus for modification of their oligosaccharides or
possible addition of O-linked oligosaccharides.
Ability of gL mutants to complement a gL− virus
The cell-mixing fusion assay is used to examine the function
of glycoprotein mutants in HSV-1-mediated cell fusion. The
glycoproteins also mediate fusion during virus entry. Discre-
pancies have been observed between virus entry and cell fusion
for HSV-1 (Cairns et al., 2005; Muggeridge, 2000; Spear and
Longnecker, 2003; Subramanian and Geraghty, 2007). HSV-1
lacking gL is defective in virus entry, probably at the step of
fusion of the viral and cellular membranes (Hutchinson et al.,
1992). We, therefore, examined the ability of the gL mutants to
complement a gL− virus using a standard approach (Cai et al.,
1988; Muggeridge et al., 1990). Vero cells were transfected with
a plasmid expressing wild-type gL or a gL mutant, and then
inoculated with a gL-null HSV-1 isolate in which the E. coli
lacZ gene replaces part of the gL ORF (Montgomery et al.,
1996). The progeny virus should contain wild-type gL or a gL
mutant on its surface. We tested the ability of complemented
viruses to enter nectin-1-expressing CHO cells (HveC-1) by
measuring β-gal activity after inoculation.
The gL mutants functioned in virus entry similarly to their
ability to contribute to cell–cell fusion. The gL mutants C160A,
155-Cys, and 155-4A-Cys were nonfunctional for complemen-
tation of the gL− virus (Fig. 5A) and viruses complemented with
T157A, R159A, or R156K functioned similarly or better than
wild-type gL (Figs. 5B and C). Defects observed in cell–cell
fusion were magnified in virus entry. Virus complemented with
R156A and R158K had significantly reduced relative function
in virus entry as compared to R156A and R158K cell–cellfusion (Figs. 5B and C). This observation was similar for
viruses complemented with R158A and R156,158,159A. While
these mutants generated cell–cell fusion at 40% and 20% of
wild-type, respectively, they displayed no virus entry (Fig. 5B).
To assess the ability of gL− complemented virus to
incorporate gH into the virion, we analyzed the complemented
virus by Western blot with anti-gH antibody (Fig. 6). The gL
mutants that mediated cell–cell fusion and virus entry (wt gL,
Fig. 6. Levels of gH on surface of complemented virus. Culture supernatants containing complemented virions were harvested and pelleted through 10% sucrose. Half
the volume of the sample was processed for SDS-PAGE and an anti-VP5 Western blot and the other half separately analyzed by SDS-PAGE and an anti-gH blot. The
presence of virus was confirmed with anti-VP5 mAb and visualized via enhanced chemiluminescence. Levels of gH on surface of complemented virus were detected
using rabbit anti-gH serum R137 and visualized via enhanced chemiluminescence. Arrows on anti-gH blot indicate nonspecific bands present in all lanes.
M/gL−=mock-transfected cells infected with gL-null HSV-1; M/gH−=mock-transfected cells infected with gH-null HSV-1; M/M=mock-transfected cells were mock
infected.
Fig. 7. Steady-state levels of gL mutants in complementing cells. Lysates were
prepared from the transfected Vero cells from the complementation assay and
were processed for SDS-PAGE and Western blotting. Steady-state levels of gL
mutants were detected using rat anti-HA and anti-rabbit IgG conjugated to Alexa
Fluor 680 dye. Quantitation was performed via LI-COR® Odyssey Infrared
Imaging System. (A) gL substitution mutants; (B) gL deletion mutants.
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tion into the viral envelope; while the gL mutants that had
reduced function or were nonfunctional in cell fusion and virus
entry assays (R158A; R156,158,159A; C160A; 155-Cys, and
155-4A-Cys) incorporated less gH into the viral particle. The
gL− virus that was complemented with R158K, a mutant that
functioned at wild-type level in cell fusion but reduced level in
virus entry, yielded gH incorporation results that were equivocal.
The level of virion-associated gH was nearly equivalent to wild-
type gL in Fig. 6. In repetitions of this experiment, virion-
associated gH appeared to be reduced for R158K compared to
gL complemented virus perhaps explaining, at least in part, the
reduction in virus entry for R158K. The polyclonal anti-gH
serum recognized proteins that migrated faster and slower than
virion-associated gH (Fig 6). Because these bands were present
in all samples, even mock transfected/mock infected, they were
likely cellular proteins non-specifically recognized by the anti-
gH polyclonal serum. The level of capsid protein VP5 was also
determined in parallel to ensure that virus was present in the
samples where no gH or virus entry was detected. Our ability to
detect VP5 levels in any given sample fluctuated from
experiment to experiment, possibly because of low levels of
virus present using this approach or because of our experimental
conditions. No particular sample consistently yielded more or
less VP5 than any other. The virus entry experiments, conducted
in parallel to those in Fig. 6, however, were consistent from
experiment to experiment. Because of these difficulties, we
could not use VP5 as a loading control to quantify the efficiency
of gH incorporation.
To ensure that gLmutants were expressed in the complement-
ing cells, we assessed their steady-state levels. Fig. 7 shows that
all the gL mutants were expressed and the varying expression
levels of gL mutants did not correlate with the ability of the
mutants to function in virus entry indicating that gL expression
was not a limiting factor in the assay (Figs. 7A and B).
Taken together, these results highlight the importance of an
Arg residue at positions 156 and 158 for incorporation of gH
into virus particles and complementation of gL− virus. Our
limited mutagenesis data further suggest that a residue with apositively charged side chain is important at position 156 but
additional mutagenesis is required to establish this point. For the
majority of gL mutants described here, the ability to comple-
ment gL-null HSV-1 was dependent on their ability to localize
gH to the viral envelope as would be expected. One possible
exception is the R156A mutant. It mediated gH incorporation
into virus particles at approximately the same level as wild-type
gL yet was reduced in ability to complement gL− virus. The
R156A mutant also displayed a modest defect in cell–cell
fusion despite wild-type ability to transport gH to the cell
surface (Fig. 4). Together, those results indicate that R156A
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transport.
Discussion
Previous deletion studies identified the 155–161 region of
HSV-1 gL as critical for gH transport to the cell surface
(Klyachkin et al., 2006). In this study, we extended our previous
findings to identify gL Cys 160, Arg156 and Arg158 as
important for gL function. In addition we report the following
findings: (i) addition of the Cys to the largest nonfunctional gL
deletion mutant did not restore function indicating that Cys 160
was necessary but not sufficient for function; (ii) simultaneously
substituting all three Arg with Ala in gL region 156–160
substantially reduced gH transport, cell fusion and virus entry;
(iii) Arg158 was important for gH transport and therefore cell
fusion and virus entry; (iv) the presence of the Arg in the 156th
position, possibly due to its positive charge, is important for cell
fusion and especially virus entry. These results are summarized
in Table 1.
The ability of gL mutants to mediate cell fusion was, for the
most part, reflected in their ability to complement a gL− virus.
Because the gL− virus is defective at membrane fusion
(Montgomery et al., 1996; Roop et al., 1993), we consider
complementation a measure of function during virus entry.
Deficiencies of gL mutants in cell fusion, however, were
exacerbated in the virus complementation assay. Mutants that
displayed any reduction in cell fusion activity displayed a
greater relative reduction for virus entry. This discrepancy may
involve the scale of membrane fusion for both processes. HSV-
1-mediated cell fusion occurs over a vast area of the plasma
membrane with a relatively large number of HSV-1 envelope
glycoprotein–receptor interactions, while envelope glycopro-
tein–receptor interactions may occur on a more limited scale for
virus entry. The increased number of glycoprotein–receptor
interactions in cell fusion may reduce the impact of gL mutant
deficiencies (such as limited gH trafficking) whereas the more
limited number of interactions occurring during virus entry may
make deficiencies more apparent. Conversely, the mutations inTable 1
Activities of gL mutants
Mutant Expression gH
binding
gH
traffickinga
Cell
fusion
Virus
entry
gL 161b + +++ ++ ++ NA
gL 155b + +++ − − NA
R156A +++ +++ +++ +++ ++
T157A +++ +++ +++ +++ +++
R158A +++ +++ + + −
R159A +++ +++ +++ +++ +++
R156,8,9A +++ +++ + + −
C160A +++ +++ − − −
R156K +++ +++ +++ +++ +++
R158K +++ +++ +++ +++ ++
155-Cys + +++ − − −
155-4A-Cys + +++ − − −
(+++) 77–100% of wild-type gL, (++) 33–77%, (+) 1–33%, (−) no activity.
a gH cell-surface expression.
b Klyachkin et al. (2006).gL may cause a relatively greater reduction of gH incorporation
into virions than a reduction of gH expression at the cell surface,
resulting in a comparatively more profound reduction in entry
of complemented virions. It is formally possible, however, that
gL may have a function in virus replication that does not involve
virus entry and the greater relative reduction in the comple-
mentation assay reflects the reduction in that role. We think this
is unlikely because the phenotype for complementation largely
correlates positively with the level of gH associated with
complemented virus. This suggests that perhaps the most
important role for gL in virus entry is to mediate appropriate
expression of gH on the virus particle.
The gL point mutants that were most defective in gL
transport to the cell surface (R158A; R156,158,159A; and
C160A) displayed the highest level of immature gL associated
with gH. This is interesting especially for the C160A mutant
because we were unable to detect any cell-surface gH when co-
expressed with C160A. If those gH/C160A heterodimers were
retained in the endoplasmic reticulum, we would expect to see
only the immature form of C160A associated with gH. Because
there is a mature form of C160A that co-immunoprecipitates
with gH, some gH/C160A heterodimers may make it to the
Golgi for continued processing and perhaps addition of
carbohydrate. This result suggests that gH/C160A heterodi-
mers, and other nonfunctional gL/gH heterodimers, may either
be halted in the Golgi or retrieved back to the endoplasmic
reticulum. We are currently investigating these possibilities for
gH/gL mutant heterodimers and for gH when expressed alone,
as well as exploring the nature of what we have called immature
and mature forms of gL and mutants.
An interesting question in HSV-1 membrane fusion is if there
is a role for gL in fusion other than ensuring gH trafficking to
the virion or cell surface. One study detected a reduction in cell
fusion by a gL mAb (Novotny et al., 1996) suggesting that gL
has a function post-gH trafficking and during the actual fusion
process. The mutant R156A mediated the cell-surface and virus
particle localization of gH at a level approximately equivalent to
that detected with wild-type gL. However, R156A mediated cell
fusion only 70% that of wild-type gL and only functioned 50%
of wild-type gL in virus entry. This result provides further
evidence that gL may be involved in membrane fusion after the
gH–gL heterodimer reaches the cell surface.
Our results indicate that Arg158 is the most important Arg
residue in the 155–161 region of HSV-1 gL. The substitution of
the positively charged Arg with the more neutral Ala rendered
gH transport and corresponding cell–cell fusion greatly
reduced, while substitution with the positively charged Lys
restored function to near wild-type levels. Arg158 could be
contributing to the structural integrity and correct conformation
of HSV-1 gL by involvement in salt bridges with negatively
charged amino acids on either gL or gH. While Arg158 may be
important in intramolecular interactions, it was not critical for
intermolecular interactions with gH, since we were able to
immunoprecipitate R158Awith gH (Fig. 3). The possibility yet
remains that Arg158 is involved in gH interactions that are not
required for binding as detected by a co-immunoprecipitation
but are critical for the function of the gH–gL heterodimer.
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cleavage site, RXXR (Bosshart et al., 1994; Molloy et al., 1992,
1994; Stadler et al., 1997) and were intrigued by the idea that the
endoprotease could be involved in gL function. This motif is
conserved in many HSV-1 and HSV-2 isolates but is absent from
gL homologs from other alphaherpesviruses. However, HSV-1
gL is larger than gL homologs present in many herpesviruses
(Duus andGrose, 1996) and cleavage after the putative furin site,
amino acids 156–159, would result in a 159-amino-acid gL
fragment very close to the size of other herpesvirus gL
homologs. The 159-amino-acid cleavage fragment would be
linked to the smaller gL fragment (approximately 64 amino
acids) via a disulfide bond. Interestingly, glycoprotein prM of
tick-borne encephalitis (TBE), which assists in folding and
trafficking of a larger class II fusion glycoprotein E, must be
cleaved by furin to render the virus infectious (Elshuber et al.,
2003; Stadler et al., 1997). The possible analogous function of
TBE prM and HSV-1 gL prompted us to examine furin cleavage
of gL and a possible role in gL function. In vitro, we observed
furin cleavage, albeit inefficient, of wild-type gL and no
cleavage of the R156,158,159A mutant (data not shown).
Although we identified the larger gL cleavage product in vitro
we failed to detect gL cleavage in the lysates of transfected or
infected CHO cells (data not shown). Furthermore, co-expres-
sion of gL and gH in furin-deficient CHO cells (CHO-FD11)
(Richards et al., 2006) yielded no difference in gH trafficking
compared to wild-type CHO cells, demonstrating that furin was
not critical for plasma membrane localization of the gH–gL
heterodimer (data not shown). Lastly, a cleavage event via furin
that was required for gL function did not fit with the results from
the Arg substitution mutagenesis. Since furin recognizes and
cleaves after the RXXR motif, and substitution of either Arg
results in an uncleavable substrate (Klenk and Garten, 1994),
mutants R156K and R159A should function poorly if furin
cleavage were required for gL function. R156K and R159A,
however, functioned similarly to wild-type gL in gH trafficking
and cell fusion. Therefore, it is unlikely that furin cleavage is
required for gL function although we cannot rule out the
possibility that other proteases might be involved in gL
processing.
Materials and methods
Cell lines, antibodies, and virus
CHO-K1 cells (ATCC) were grown in F12 medium, 7% fetal
bovine serum (FBS) and penicillin/streptomycin. Vero cells
(provided by P. Spear) were grown in DMEM containing 7%
serum and penicillin/streptomycin. Anti-gH mAb 52S hybri-
doma (Showalter et al., 1981) was purchased from the ATCC.
Anti-gH serum R137 was provided by R. Eisenberg and G.
Cohen. Anti-VP5 mAb was purchased from Virusys (cat
#HA018-100) (Mullen et al., 1995). Rat anti-hemagglutinin
(HA) was from Roche. Anti-rat Alexa Fluor 680-conjugated IgG
was from Molecular Probes. The anti-mouse biotin-conjugated
antibody was from Sigma. HRP-conjugated anti-rat IgG and
HRP-conjugated streptavidin were from Amersham Bios-ciences. HSV-1(KOS)tk-12 and HSV-1(KOS)gL86 (gL−) virus
isolates were provided by P. Spear. The CHO-FD11 cells
(Richards et al., 2006) were obtained from S. Leppla (National
Institutes of Health).
Plasmids
Plasmids expressing HSV-1 gB (pPEP98), gD (pPEP99) or
gH (pPEP100) and the plasmid expressing T7 RNA polymerase
(pT7pol) (Pertel et al., 2001) were provided by P. Pertel (Bayer
Pharmaceuticals, West Haven, CT, USA). The plasmids expres-
sing nectin-1 (pCJ4) and CD4 (pBG53) have been described
previously (Geraghty et al., 2001, 2000). The plasmid expressing
β-Gal under the control of the T7 promoter (pG1NT7β-gal)
(Nussbaum et al., 1994) was provided by E. Berger (National
Institutes of Health, MD, USA). The plasmid expressing an HA
epitope-tagged gL (pMN116) (Novotny et al., 1996) was
provided by P. Spear (Northwestern University, IL, USA).
The gL deletion mutants were created by amplifying
pMN116 with primer HSVgL5 (5′-CTGAAGCTTATGGGGA-
TTTTGGGTTGGGGTCG) and one of the following primers:
155-Cys (5′-TGAATTCACACGAATAGTCAAAGTTCACA-
CACCCA), 155-4A-Cys (5′-TGAATTCACACGCCGCCGCC-
GCCGAATAGTCAAAGTTCACACACCCA). The PCR
products were gel purified and digested with enzymes EcoRI
and HindIII. The products were ligated into pMN116 that had
previously been digested with EcoRI/HindIII. The gL
substitution mutants were created using the QuikChange site-
directed mutagenesis kit (Stratagene Cloning Systems) accord-
ing to the manufacturer's instructions (using plasmid pMN116
as PCR template): R156A forward: 5′-CTTTGACTATTCGG-
CGACCCGCCGGTGTGTAGGG; R156A reverse complement:
5′-CCCTACACACCGGCGGGTCGCCGAATAGTCAAAG;
T157A forward: 5′-GTGAACTTTGACTATTCGCGCGCCC-
GCCGGTGTGTAGGG; T157A reverse complement: 5′-GTC-
CGGCGGCAGAACCGGTGTCGCTCCAGACGTTCC;
R158A forward: 5′-GACTATTCGCGCACCGCGCGCTGTG-
TAGGGCG; R158A reverse complement: 5′-CGCCCTACA-
CAGCGCGCGGTGCGCGAATAGTC; R159A forward: 5′-
CTATTCGCGCACGCGCGCGTGTGTAGGGCGACAGG;
R159A reverse complement: 5′-CCTGTCGCCCTACACACG-
CGCGCGTGCGCGAATAG; C160A forward: 5′-CGC-
GCACCCGCCGCGCTGTAGGGCGACAGGATTTG;
C160A reverse complement: 5′-CAAATCCTGTCGCCCT-
ACAGCGCGGCGGGTGCGCG; R156,158,159A forward:
5′-GACTATTCGGCCACGGCCGCCTGTGTAGGGCG;
R156,158,159A reverse complement: 5′-CGCCCTACAC-
AGGCGGCCGTGGCCGAATAGTC; R156K forward: 5′-
GTGAACTTTGACTATTCGAAAACCCGCCGGTGTGTAG-
GGCGAC; R156K reverse complement: 5′-GTCGCCCTACA-
CACCGGCGGGTTTTCGAATAGTCAAAGTTCAC; R158K
forward: 5′-GAACTTTGACTATTCGCGAACCAAGCGCTG-
TGTAGGGCGACAGG; R158K reverse complement: 5′-CCT-
GTCGCCCTACACAGCGCTTGGTTCGCGAATAGT-
CAAAGTTC. All substitution mutants are listed in Fig. 1. All
newly created plasmids were verified by DNA sequencing
(Davis Sequencing, Davis, CA, USA).
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In each well of a 6-well plate, approximately 80% confluent
CHO-K1 cells were incubated with 1.5 μg of plasmid DNA and
5 μl Lipofectamine (Invitrogen) according to the manufacturer's
instructions. The cells were incubated with the transfection
reagents for 6–8 h and the transfection medium was replaced
with F12/20% FBS.
Co-immunoprecipitation/Western blot
CHO-K1 cells were transfected with plasmids expressing gH
and gL, gH and a gL mutant, gH and control plasmid or gL and
control plasmid (1:1 molar ratio). Co-immunoprecipitations
were carried out with mAb 52S as described previously (Jones
and Geraghty, 2004). Equivalent volumes of immunoprecipi-
tates were separated on a 15% SDS–polyacrylamide gel and
transferred to nitrocellulose for Western blot analysis using an
anti-HA mAb as described previously (Jones and Geraghty,
2004). For the quantification of gL mutant expression, the
antibodies used were rat anti-HA antibody (1:2500 dilution) and
anti-rat Alexa Fluor 680-conjugated IgG (1:5000). Forty
micrograms of lysate protein was loaded for each sample, and
the LI-COR® Odyssey Infrared Imaging System was used.
Cell-mixing fusion assay and cellular ELISA (CELISA)
The cell-mixing fusion assay was described previously
(Jones and Geraghty, 2004). CHO-K1 effector cells were
transfected with the plasmids expressing the HSV-1 fusion
glycoproteins (gB, gD, gH and gL) and T7 RNA polymerase (at
a 1:1:1:1:1 molar ratio). A plasmid expressing a gL mutant or a
control plasmid (pcDNA3; Invitrogen) was substituted indivi-
dually for the wild-type gL plasmid. Target CHO-K1 cells were
transfected with the plasmid expressing nectin-1 and
pG1NT7β-gal (3:1 molar ratio). Twenty-four hours post-
transfection, effector and target cells were mixed in a 1:1 ratio
and co-cultivated for 18 h on a 96-well dish. β-Gal activity was
measured by using the substrate CPRG (0.7 μg/μl in PBS with
0.5% Nonidet P40) and spectrometry. Multiple readings of each
sample were taken to ensure the linear relationship of β-Gal
activity over time.
The CELISA assay was performed as described previously
(Jones and Geraghty, 2004). CHO-K1 effector cells, transfected
for the fusion assay, were replated on a 96-well plate. The anti-
gH 52S mAb was used at a 1:500 dilution. Biotin-conjugated
anti-mouse secondary antibody was used at a 1:500 dilution.
AMDEX streptavidin-conjugated horseradish peroxidase
(Amersham Biosciences) was used at a 1:20,000 dilution.
Virus complementation assay
The complementation assay was performed as described by
others (Chiang et al., 1994; Connolly et al., 2005) with several
modifications. Vero cells were transfected for 4 h with plasmids
expressing the gL mutants and a day later inoculated with HSV-
1 (KOS)(gL86) grown on complementing cells. HSV-1 (KOS)(gL86) is a gL mutant virus with the E. coli lacZ gene replacing
part of the gL ORF. Inoculations were carried out at an MOI of 8
in DMEM supplemented with 5% heat-inactivated serum
(DMEV) for 2 h at 37 °C. After 2 h, medium was removed
and extracellular virus was inactivated with citrate buffer (pH
3.0) for 1 min followed by three washes with DMEV. The cells
were then overlaid with fresh DMEV and incubated for 48 h at
37 °C. The culture supernatant containing extracellular virus
was harvested and subjected to a low-speed spin to pellet cells
and debris. The virus-containing supernatant was then diluted 2-
fold, 4-fold, or 8-fold in DMEV and overlaid onto a 96-well
plate containing nectin-1-expressing CHO (HveC-1) cells for
2 h. The infection was followed by low pH inactivation of
extracellular virus, 3 washes, and incubation in F12 7% FBS for
4 h. The cells were then lysed and β-gal activity determined as a
measure of virus entry (Montgomery et al., 1996).
To assess the presence of gH on the complemented virus, the
supernatant containing the complemented virus was processed
by two different methods to concentrate the virus each yielding
nearly identical results. The supernatant was either (i) spin-
concentrated in Microcon® Centrifugal Filter Units (100-kDa
cutoff) according to the manufacturer's instructions or (ii)
pelleted through a 10% sucrose cushion at 48,000×g for 1 h at
4 °C. Equivalent volumes of concentrated supernatant were
separated on a 10% SDS–polyacrylamide gel and transferred to
nitrocellulose for Western blot analysis using R137 anti-gH
serum and anti-VP5 mAb.
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